1. Home
  2. HUN vs IMNM Comparison

HUN vs IMNM Comparison

Compare HUN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$10.86

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$24.68

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
IMNM
Founded
1970
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
HUN
IMNM
Price
$10.86
$24.68
Analyst Decision
Hold
Strong Buy
Analyst Count
11
9
Target Price
$11.00
$31.22
AVG Volume (30 Days)
4.7M
2.1M
Earning Date
02-17-2026
03-18-2026
Dividend Yield
3.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,780,000,000.00
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.32
$11.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.30
$5.15
52 Week High
$18.53
$26.63

Technical Indicators

Market Signals
Indicator
HUN
IMNM
Relative Strength Index (RSI) 45.74 61.80
Support Level $11.16 $24.82
Resistance Level $12.41 $26.63
Average True Range (ATR) 0.47 1.53
MACD -0.14 0.13
Stochastic Oscillator 5.56 73.17

Price Performance

Historical Comparison
HUN
IMNM

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: